MILR1

Across TCGA pan-cancer cohorts, MILR1 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated MILR1 data layer compared with 21 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher MILR1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated MILR1 expression acts as an unfavorable survival marker.

PDAC, HNSC, and GBM are the cancer types where MILR1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.681	0.822	.002	56	view →
HNSC	OS	Median	All	0.664	0.885	.025	3	view →
GBM	OS	Quartile	All	0.486	0.707	.041	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

MILR1–PDAC (DFS)

Open the PDAC breakdown →